Replies to post #4335 on NorthWest Biotherapeutics Inc (NWBO)

[ou71764]

Thanks, Flip, I can see now that it is logical that the chemo continue. That neutralizes the chemo/toxicity issue for DCVax-L since all patients receive it.

I'm trying to decide if the odds of an early halt are actually greater than I originally thought.

[SuperSquirrel]

concurrent chemo is not used with direct

This is one of the reasons I have such high hopes for Direct. DCVax-L not only has to get the immune system to fight the cancer, it also has to help overcome the toxic-carcinogenic chemo. For NWBO investors, all we need a significant increase to "std care" for survival to get a nice valuation increase which should provide the funds needed to bring Direct through clinicals. JMHO